Cargando…

Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model

PURPOSE: There is growing evidence that tumor-specific immune responses play an important role in anti-cancer therapy, including radiotherapy. Using mouse tumor models we demonstrate that irradiation-induced anti-tumor immunity is essential for the therapeutic efficacy of irradiation and can be augm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimoto, Yuya, Suzuki, Yoshiyuki, Mimura, Kousaku, Ando, Ken, Oike, Takahiro, Sato, Hiro, Okonogi, Noriyuki, Maruyama, Takanori, Izawa, Shinichiro, Noda, Shin-ei, Fujii, Hideki, Kono, Koji, Nakano, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970971/ https://www.ncbi.nlm.nih.gov/pubmed/24686897 http://dx.doi.org/10.1371/journal.pone.0092572

Ejemplares similares

Carbon-ion beams induce production of an immune mediator protein, high mobility group box 1, at levels comparable with X-ray irradiation
por: Yoshimoto, Yuya, et al.
Publicado: (2015)

HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer
por: Sato, Hiro, et al.
Publicado: (2014)

Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions
por: Ushijima, Hiroki, et al.
Publicado: (2015)

High linear energy transfer carbon-ion irradiation increases the release of the immune mediator high mobility group box 1 from human cancer cells
por: Onishi, Masahiro, et al.
Publicado: (2018)

Translational Research to Improve the Efficacy of Carbon Ion Radiotherapy: Experience of Gunma University
por: Oike, Takahiro, et al.
Publicado: (2016)

Phase I Study of Carbon Ion Radiotherapy and Image-Guided Brachytherapy for Locally Advanced Cervical Cancer
por: Ohno, Tatsuya, et al.
Publicado: (2018)

Treatment outcomes of patients with adenocarcinoma of the uterine cervix after definitive radiotherapy and the prognostic impact of tumor-infiltrating CD8(+) lymphocytes in pre-treatment biopsy specimens: a multi-institutional retrospective study
por: Miyasaka, Yuhei, et al.
Publicado: (2020)

An abscopal effect in a case of concomitant treatment of locally and peritoneally recurrent gastric cancer using adoptive T‐cell immunotherapy and radiotherapy
por: Sato, Hiro, et al.
Publicado: (2017)

Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy
por: Oike, Takahiro, et al.
Publicado: (2013)

Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy
por: Nuryadi, Endang, et al.
Publicado: (2018)

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
por: Sato, Hiro, et al.
Publicado: (2020)

In-room computed tomography–based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study
por: Ohno, Tatsuya, et al.
Publicado: (2017)

Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression
por: Inoue, Masayuki, et al.
Publicado: (2012)

Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
por: Oike, Takahiro, et al.
Publicado: (2014)

High tumor mutational burden predicts worse prognosis for cervical cancer treated with radiotherapy
por: Ota, Norichika, et al.
Publicado: (2021)

Visualization of complex DNA double-strand breaks in a tumor treated with carbon ion radiotherapy
por: Oike, Takahiro, et al.
Publicado: (2016)

Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
por: Kono, Koji, et al.
Publicado: (2013)

CTLA-4 blockade: therapeutic potential in cancer treatments
por: Tarhini, Ahmad A, et al.
Publicado: (2010)

Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix
por: Okonogi, Noriyuki, et al.
Publicado: (2021)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Protective Immunity to Nematode Infection Is Induced by CTLA-4 Blockade
por: McCoy, Kathy, et al.
Publicado: (1997)

CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
por: Waitz, Rebecca, et al.
Publicado: (2012)

S43. Dendritic cell vaccination combined with CTLA4 blockade
por: Thielemans, K, et al.
Publicado: (2014)

CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic
por: Callahan, Margaret K., et al.
Publicado: (2015)

A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
por: Du, Xuexiang, et al.
Publicado: (2018)

Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
por: Wilkins, Anna, et al.
Publicado: (2019)

Radiotherapy induces responses of lung cancer to CTLA-4 blockade
por: Formenti, Silvia C., et al.
Publicado: (2018)

A retrospective study of small-pelvis radiotherapy plus image-guided brachytherapy in stage I–II non-bulky cervical squamous cell carcinoma
por: Yoshimoto, Yuya, et al.
Publicado: (2022)

Efficacy and Feasibility of Salvage Re-Irradiation with CyberKnife for In-Field Neck Lymph Node Recurrence: A Retrospective Study
por: Kobayashi, Daijiro, et al.
Publicado: (2019)

Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study
por: Otani, Yuki, et al.
Publicado: (2021)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

Leptomeningeal metastasis of uterine cervical cancer 17 years after primary tumor treatment
por: Oike, Takahiro, et al.
Publicado: (2015)

Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
por: Wada, Satoshi, et al.
Publicado: (2013)

CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
por: Camacho, Luis H
Publicado: (2015)

The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
por: Zhang, Shashuang, et al.
Publicado: (2020)

A T cell repertoire timestamp is at the core of responsiveness to CTLA-4 blockade
por: Philip, Hagit, et al.
Publicado: (2021)

DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
por: Sato, Hiro, et al.
Publicado: (2017)

Granulocyte‐colony stimulating factor‐producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review
por: Shiba, Shintaro, et al.
Publicado: (2020)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022)

CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
por: von Euw, Erika, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kguibls9racbcffun9dqkei2cp